Læknablaðið - 15.06.1995, Síða 22

468
LÆKNABLAÐIÐ 1995; 81
stract.) Eur J Clin Microbiol Infect Dis 1992; 11: 836-8.
22. Hríbalová V. Strepplococcus pyogenesis and the toxic
shock syndrome. Ann Intern Med 1988; 108: bls.
23. Simonart T, Simonart JT, Schoutens C, Parent D, Wul-
leman P, Struelens M. Strepptococcus beta hemolytic
necrotizing fasciitis. 5 cases in the Brussels Area. (Ab-
stract.) Ann Dermatol Venerol 1993; 120: 441-3.
24. Verburgh CA, Hendriks WD, Ligthart J, Beghout A.
Necrotizing fasciitis caused by group A beta-hemolytic
streptococci. (Abstract.) Ned Tijdshcr Geneeskd 1993;
137: 607-9.
25. Shimizu Y, Ohymama A, Kasama K, Miyazaki M, Ooe
K, Ookochi Y, et al. Case report of toxic-like syndrome
due to group A streptococcal infection. (Abstract.) Kan-
senshogaku-Zasshi 1993; 67: 236-9.
26. Hansman D, Jarvinen A. Group A strepptococcal in-
fections and a toxic shock-like syndrome. (Letter to the
editor.) N Engl J Med 1989; 321: 1546.
27. DcmersB, Simor AE, Vellend H, Schlievert PM, Byme
S, Jamieson F, et al. Severe invasive group A streptococ-
cal infections in Ontario, Canada: 1987-1991. Clin Infect
Dis 1993; 16: 792-800.
28. Kaplan EL, Johnson DR, Cleary PP. Group A strepto-
coccal serotypes isolated from patients and siblings con-
tacts during the resurgence of rheumatic fever in the
United States in the mid 1980’s. J Infect Dis 1989; 159:
101-3.
29. Invasive streptococci. (Editorial.) Lancet 1989; II: 1255.
30. Brandtzæg P, Gaustad P, Vanberg PJ, Medbp S, Ledaal
P, Reigstad H, et al. Kliniske sykdomsbilder forársaket
av gruppe A streptokokker. Tidsskr Nor Lægeforen
1990; 110: 2629-33.
31. Höiby EA, Gaustad P, Aasen S, Martin PR. Sykdom
forársaket av Streptococcus pyogenesis i Norge 1975-89.
Tidsskr Nor Lægeforen 1990; 110: 2625-8.
32. Willoughby R, Greenberg RN. The toxic shock syn-
drome and streptococcal pyrogenic exotoxins. Ann In-
tern Med 1983; 98: 559.
33. Boyce JM. Severe streptococcal axillary lymphadenitis.
N Engl J Med 1990; 323: 655-8.
34. The working group on severe streptococcal infections.
Defining the group A streptococcal toxic shock syn-
drome. JAMA 1993; 269: 390-1.
35. Hjortdahl P, Halstensen A, Höiby EA. Differnensial-
diagnostiske utfordringer ved betahemolytiske strepto-
kokkinfeksjoner. Tidsskr Nor Lægeforen 1990; 110:
2634-7.
36. Halstensen A, Brandtzæg P, Andrew M, Hpiby EA.
Hjortdahl P, Gaustad P. Behandling av infeksjoner fo-
rársaket av gruppe A- betahemolytiske streptokokker.
Tidsskr Nor Lægeforen 1990; 110: 2637^10.
37. Todd J, Fishaut M. Toxic syndrome associated with
phage-group-I staphylococci. Lancet 1978; 2: 1116-8.
38. Davis JP, Chesney PJ, Wand PJ, La Ventura M. Toxic-
shock syndrome. Epidemiologic features, recurrence,
risk factors and preventions. N Engl J Med 1980; 303:
1429-35.
39. Kass EH, Parsonnet J. On the pathogenesis of toxic
shock syndrome. Rev Infect Dis 1987; 9: 482-9.
40. Stevens DL, Gibbson AE, Bergstrom R, Winn V. The
Eagle effect revisited: efficacy of clindamycin, erythro-
mycin and penecillin in the treatment of streptococcal
myositis. J Infect Dis 1988; 158: 23-8.
41. Reed WP, Metzler C, Albrigth E. Streptococcal adher-
ence to Langerhans cells: A possible step in the pathoge-
nesis of streptococcal pharyngitis. (Abstract.) Clin Im-
munol Immunopathol 1994; 70: 28-31.
42. Schmidt KH, Wiesner J, Gerlach D, Reichardt W, Oze-
gowski JH, Kohler W. Susceptibililty of chicken em-
bryos to group A streptococci: correlation with fibrino-
gen binding. (Abstract.) FEMS Immunol Med Micro-
biol 1993; 7: 231-40.
43. Schwartz B, Facklam RR, Breiman RF. Changing epi-
demiology of group A streptococcal infection in the
USA. Lancet 1990; 336: 1167-71.
44. Talkington DF, Schwartz B, Black CM, Todd JK, Elliot
J, Breiman RF, et al. Association of phenotypic and
genotypic characteristic of invasive Streptococcus pyoge-
nesis isolates with clinical components of streptococcal
toxic shock syndrome. Infect Immun 1993; 61: 3369-74.
45. Hackett SP, Stevens DL. Streptococcal toxic shock syn-
drome: synthesis of tumor necrosis factor and interleu-
kin-1 monocytes stimulated with pyrogenic exotoxin A
and streptolysin O. J Infect Dis 1992; 165: 879-85.
46. Cleary PP, Kaplan EL, Handley JP, Wlazlo A, Kim
MH, Hauser AR, Schlievert PM. Clonal basis for re-
surgence of serious streptococcus pyogenesis disease in
the 1980’s. Lancet 1992; 339: 518-21.
47. Musser JM, Kapur V, Kanjilal S, Shah U, Musher DM,
Barg NL, et al. Geographic and temporal distribution
and molecular characterization of highly pathogenic
clones of Streptococcus pyogenes expressing allelic var-
iants of pyrogenic exotoxin A ( scarlet fever toxin). J
Infect Dis 1993; 167: 337^16.
48. Reichart W, Miiller-Alouf H, Alouf JE, Köhler W.
Erythrogenic toxins A, B and C: occurrence of the genes
and exotoxin formation from clinical Streptococcus pyo-
genes strains associated with streptococcal toxic shock-
like syndrome. FEMS Microbiolgy Letters 1992; 100:
313-22.
49. Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC.
Improved results from a stanardized approach in treat-
ing patients with necrotizing fasciitis. Ann Surg 1986;
206: 661-5.
50. Aasen AO, Ruud TE, Haffner J, Ræder M, Solheim K,
Stadaas JO, et al. Kirurgisk behandling ved nekrotis-
erande fasciitis. Tidsskr Nor Lægeforen 1989; 109: 2768-
72.
51. Kinn I. Nekrotiserande fasciit fremkalt av gruppe A-
streptokokker. Tidsskr Nor Lægeforen 1990; 110:
2641-3.
52. Barker FG, Leppard BJ, Seal DV. Strepptococcal ne-
crotising fasciitis: comparison between histological and
clinical features. J Clin Pathol 1987; 40: 335-41.
53. Guiliano A, Lewis F, Hadley K, Blaisdell FW. Bacte-
riology of necrotizing fasciitis. Am J Surg 1977; 134:
52-7.
54. Frick T, Simmen HP, Kach K, Duff C, Hoffman R,
Zellweger G, et al. Schwere nekrotisierende fasciitis.
(Abstract.) Helv Chir Acta 1992; 59: 341-4.
55. Zittergruen M, Grose C. Magnetic resonance for early
diagnosis of necrotizing fasciitis. (Abstract.) Pediatr
Emerg Care 1993; 9: 26-8.
56. Burge TS, Watson JD. Necrotising faciitis. Br Med J
1994; 308: 1453—4.
57. Kristinsson KG, Gunnlaugsson S. Streptococcus pyo-
genes — Vaxandi tíðni sýkinga — sýklalyfjanæmi.
Læknablaðið/Fréttbréf lækna 1993; 11 (3): 28-9.
58. Gunnlaugsson S, Kristinsson KG, Steingrimsson Ó.
Streptococcus pyogenes — í nýrri sókn. Læknablaðið
1994; 80/Fylgirit 25: 23.
59. Gunnlaugsson S, Kristinsson KG, Steingrímsson Ó. Fa-
raldsfræði og stofngerðir Streptococcus pyogenes á Is-
landi. Læknablaðið 1992; 78/Fylgirit 21: 35.
60. Guðmundsdóttir A, Kristinsson KG, Teitsdóttir I, An-
tonsdóttir S. Yfirlit yfir blóðsýkingar á Landspítalanum
1993. Læknablaðið 1994; 80/Fylgirit 25: 25.